The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 54 of the 100 sources its claims cite were checked for support.
Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025)
Open accessAbstract
Objectives: Medication adherence in elderly patients is shaped by cognitive, behavioral, systemic, and socioeconomic factors. This review aimed to identify determinants and effective strategies to improve adherence in older adults. Methods: A systematic search of PubMed, Scopus, and ScienceDirect (2015–2025) followed PRISMA 2020 guidelines. From 5116 records, 53 studies met inclusion criteria. Randomized controlled trials were meta-analyzed using standardized mean differences under a random-effects model. Risk of bias in the 10 pooled trials was assessed using the Cochrane RoB 2 tool, and certainty of evidence was evaluated using the GRADE framework. Results: Adherence ranged from 25.3% in institutionalized patients to 97.6% in pharmacist-led schizophrenia programs. Cognitive impairment and frailty reduced adherence (54.2%), while caregiver involvement improved rates, especially in dementia and schizophrenia (77.4–97.6%). Socioeconomic barriers, including medication cost, contributed to nonadherence but were mitigated by subsidies. Digital tools enhanced adherence in chronic disease, and machine learning models accurately predicted nonadherence (AUC up to 0.935). Effective interventions—caregiver support, digital platforms, and single-pill regimens—increased adherence by 25–59% and reduced cardiovascular events. The meta-analysis demonstrated a significant pooled effect (Standardized Mean Difference, SMD = 0.71, 95% CI: 0.11–1.54), although heterogeneity was high (I2 = 99%). The RoB 2 assessment of the 10 pooled trials identified 2 at low risk, 4 with some concerns, and 4 at high risk of bias; the GRADE certainty of evidence was rated Very Low. Conclusions: Multiple factors, including frailty, cognitive deficits, socioeconomic barriers, regimen complexity, and the level of caregiver support, appear to be consistently associated with medication adherence in older adults. Strategies such as caregiver engagement, digital health tools, regimen simplification, and mental health support may contribute to improved adherence, although effect sizes vary considerably across study contexts. Given the substantial heterogeneity, Very Low certainty of evidence (GRADE), and variable study quality, findings should be interpreted with caution. System-level reforms, financial assistance programs, and culturally tailored approaches may further support adherence, while the successful implementation of digital health solutions will require addressing literacy, accessibility, and integration challenges.
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis found that medication-adherence interventions for older adults generally favored the intervention arm, with a pooled standardized mean difference of 0.71 (95% CI: 0.11–1.54) across 10 trials. However, the evidence was rated Very Low certainty because of very high heterogeneity (I2 = 99%) and substantial risk of bias.
## Key findings
- The search identified 5,116 records; after screening and full-text review, 53 studies were included in the systematic review, and 10 trials with extractable adherence data were pooled in the meta-analysis (combined N = 3,733).
- The pooled meta-analytic effect was significant: SMD = 0.71 (95% CI: 0.11–1.54), but heterogeneity was very high (I2 = 99%).
- Risk of bias among the 10 pooled trials was mixed: 2 were rated low risk, 4 had some concerns, and 4 were high risk.
- Subgroup summaries all favored intervention: digital/e-health interventions (6 trials), caregiver-supported/educational strategies (2 trials), and pharmacological/regimen-level interventions (3 trials), with the largest reported SMDs in digital interventions (0.08 to 2.31) and more modest effects for pharmacological/management interventions (−0.05 to 0.32).
## Methods
- Systematic review and meta-analysis following PRISMA 2020, with searches of PubMed, Scopus, and ScienceDirect for English-language human studies published from 2015–2025.
- Included English-language, peer-reviewed original research reporting quantitative medication-adherence outcomes in older adults; 53 studies met criteria, and 10 randomized or quasi-experimental trials were pooled.
- Effect sizes were converted to standardized mean differences (Hedges g) and analyzed in RevMan 5.3 using an inverse-variance random-effects model; risk of bias was assessed with Cochrane RoB 2, and certainty with GRADE.
## Limitations
- The paper states the overall certainty of evidence was Very Low because of serious risk of bias, very serious inconsistency, and high heterogeneity (I2 = 99%).
- The authors note that only 10 studies were eligible for pooling, which prevented formal meta-regression and funnel-plot assessment; selective outcome reporting remains a plausible concern.
- Evident from the text: many included studies relied on self-reported adherence, and the non-interventional studies were mostly cross-sectional, observational, small convenience samples with limited confounder adjustment, which weakens the qualitative synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
45 Valid · 7 Not valid · 42 Not checked · 57 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Sütlü’s study in Turkey showed 61.7% adherence, with education level and polypharmacy as significant predictors (p < 0.05) [40].”
§ Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025) > 4. Discussion > 4.1. Cognitive Impairment and Frailty
What the sources say
- Disputedcites [40] Sutlu, 2023, Medication Adherence and its Affecting Factors among Older Adults, Anatol. J. Fam. Med. sourceExperimental — accuracy not yet measured
Our copy contradicts the claim on both counts. The RESULTS section reports 256 (73.6%) of 348 older adults with no medication nonadherence and 92 (26.4%) with low adherence by MMAS-4 — not 61.7% — and the DISCUSSION repeats 73.6%/26.4%. Table 2 (Sociodemographic and drug use characteristics according to medication adherence) gives level of education p = 0.377, i.e. explicitly non-significant at the paper's stated p<0.05 threshold; number of medicines used was significant only in univariate chi-square (p = 0.022) and the paper's logistic model named insufficient/barely sufficient income, not recognizing one's medicines, and belief in intravenous superiority as the associated factors (Nagelkerke R² = 0.107, p<0.001), not education or polypharmacy. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Sütlü’s study in Turkey showed 61.7% adherence, with education level and polypharmacy as significant predictors (p < 0.05) [40].”
§ Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025) > 4. Discussion > 4.1. Cognitive Impairment and Frailty
What the sources say
- Disputedcites [40] Sutlu, 2023, Medication Adherence and its Affecting Factors among Older Adults, Anatol. J. Fam. Med. sourceExperimental — accuracy not yet measured
Our copy contradicts two of the three elements attributed to Sütlü (2023). The RESULTS (p. n/a, Results section) report adherence as 256/348 = 73.6% with no nonadherence and 92 (26.4%) low adherence by MMAS-4 — nowhere near the 61.7% the citing sentence assigns, and no 61.7% adherence figure appears in the paper. Table 2 (Sociodemographic and drug use characteristics according to medication adherence) gives 'Level of education ... p = 0.377', i.e. education was explicitly non-significant, so calling it a significant predictor is contrary to the source. Number of medicines used was significant only in univariate chi-square (p = 0.022, and in the direction of better adherence with >6 medicines), and the logistic model in RESULTS identified income, failure to recognize one's medicines and belief in the superiority of intravenous medicines as the factors — not polypharmacy. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Solmaz et al. reported SMS reminders increased medication adherence by 20% and dietary compliance by 15% in cardiovascular patients (p < 0.01) [18].”
§ Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025) > 4. Discussion > 4.3. Digital Health Adoption
What the sources say
- Disputedcites [18] Solmaz, 2024, The role of training and medication reminder wristwatch in adherence to treatment in geriatric patients diagnosed with hypertension: A randomized controlled trial, Geriatr. Gerontol. Int. sourceExperimental — accuracy not yet measured
The Methods (Medication reminder wristwatch application; page unavailable) say participants used alarm-equipped wristwatches, not SMS reminders. The Results (Pre/postintervention changes; page unavailable) report adherence-related scale scores but no 15% increase in dietary compliance. The attributed intervention and outcome therefore differ from what Solmaz et al. report. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, adherence among elderly people remains suboptimal, ranging from 25% in institutionalized settings to over 90% in controlled care [4,5].”
§ Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025) > 1. Introduction
What the sources say
- Partly supportedcites [4] Algameel, 2020, Patterns of medication use and adherence to medications among residents in the elderly homes, Pak. J. Med. Sci. sourceExperimental — accuracy not yet measured
The Results (Table III) report that 25.3% of the 63 elderly-home residents were fully adherent, supporting the institutionalized-setting figure. The paper does not report adherence above 90% in controlled care, so it does not support the other end of the claimed range. (LLM, conf=0.88)
- Not checked yetcites [5] Cheng, 2023, Adherence to topical glaucoma therapy in patients attending virtual clinics, Eye source
Checked before — its earlier verdict is held back until a new check runs.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Dong et al. found that Medicare Part D medication therapy management (MTM) increased adherence by 9.3% in Black patients and 7.1% in Hispanic patients, reducing disparities in Alzheimer’s treatment [38].”
§ Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025) > 4. Discussion > 4.1. Cognitive Impairment and Frailty
What the sources say
- Partly supportedcites [38] Dong, 2024, Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer’s disease and related dementias: An observational study, Explor. Res. Clin. Soc. Pharm. sourceExperimental — accuracy not yet measured
The Results report lower Black–White disparities in nonadherence associated with MTM enrollment, but not a 9.3% increase in adherence among Black patients. In the intervention group, the reported Black nonadherence rate fell from 22.4% in 2016 to 18.5% in 2017; the study is observational and does not establish that MTM caused the change. (LLM, conf=0.89)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
78 more claims · 31 with their cited sources checked
Create a free account to see all 151 claims and to verify the 12 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 46
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025) > 3. Results > 3.4. Subgroup Summaries and Sensitivity Analysis
“Subgroup summaries among the 10 meta-analyzed trials showed that 6 evaluated digital or e-health interventions, 2 tested caregiver-supported or educational strategies and 3 involved pharmacological management or regimen-level interventions.”
§ Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025) > 3. Results > 3.1. Study Selection
“Of the 53 included studies, 10 randomized or quasi-experimental trials provided extractable, comparable adherence data and were pooled (combined N = 3733).”
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Akhu‐Zaheya, L., & Shiyab, W. (2016) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2016.12.003 · Cited by 106
(2020) · PubMed · doi:10.6004/jnccn.2019.7354 · Cited by 99
Liu, X., Thompson, J., Dong, H., Sweeney, S., Li, X., Yuan, Y., Wang, X., He, W., Thomas, B., Xu, C., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00068-2 · Cited by 69
Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial
Campbell, N. L., Perkins, A. J., Gao, S., Skaar, T. C., Li, L., Hendrie, H. C., Fowler, N., Callahan, C. M., & Boustani, M. A. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14827 · Cited by 58
Dierick, B. J. H., Achterbosch, M., Eikholt, A. A., Been-Buck, S., Klemmeier, T., van de Hei, S. J., Hagedoorn, P., Kerstjens, H. A. M., Kocks, J. W. H., & van Boven, J. F. M. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107376 · Cited by 44
Predictors of Medication Adherence in the Elderly: The Role of Mental Health
Rodgers, J. E., Thudium, E. M., Beyhaghi, H., Sueta, C. A., Alburikan, K. A., Kucharska‐Newton, A., Chang, P. P., & Stearns, S. C. (2017) · Medical Care Research and Review · doi:10.1177/1077558717696992 · Cited by 39
Senoo, K., Miki, T., Ohkura, T., Iwakoshi, H., Nishimura, T., Shiraishi, H., Teramukai, S., & Matoba, S. (2022) · JMIR mHealth and uHealth · doi:10.2196/30807 · Cited by 36 · cited 1×
“%) compared to non-users (78.6%, p < 0.01), suggesting that digital tools can enhance medication management in elderly populations [46].”
InfluentialPark, Y., Kim, S. R., So, H. Y., Jo, S., Lee, S. H., Hwang, Y. S., Kim, M. S., & Chung, S. J. (2022) · Geriatric Nursing · doi:10.1016/j.gerinurse.2022.05.003 · Cited by 30
O'Conor, R., Russell, A. M., Pack, A., Oladejo, D., Filec, S., Rogalski, E., Morhardt, D., Lindquist, L. A., & Wolf, M. S. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19065 · Cited by 28
Research works printed but not linked: 1
- Lee, 2018, Optimizing medications in older adults with cognitive impairment, Can. Fam. Phys., 64, 646
Cited by
Bartusik‐Aebisher, D., Bania, K., George, B. P. A., Dynarowicz, K., & Aebisher, D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114359 · Cited by 2
Zhang, J., Zhao, J.-J., Zhang, L., 史铁英, & Zhang, X. (2026) · Journal of Clinical Nursing · doi:10.1111/jocn.70398
Long, L., Zhou, L., Li, W., Chen, P., Jiu-lin, G., & Chen, Z. (2026) · Journal of Medical Internet Research · doi:10.2196/97466
Zhang, T., Li, D., Ning, Y., Shi, J., & Hu, Y. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/8814045
Salis, F., Soler-Blanco, N., Molist‐Brunet, N., Gual, N., Ribera, A., Cherubini, A., Inzitari, M., & de Andrés-Lázaro, A. M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1857969
Metadata
- Authors
- Mehany, O., Artner, A., Sebők, S., Hankó, B., & Zelkó, R.
- Affiliations
- Semmelweis University (HU)
- Corresponding author
- Zelkó, Romána
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2026-03-09
- Volume
- 15
- Issue
- 5
- Pages
- 2069
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC12986251
- OpenAlex
- W7134246012
- Cited by
- 6
- References
- 43
- Citations by year
- 2026: 6
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication adherence, older adults, multilevel interventions, cognitive impairment, frailty, caregiver involvement, socioeconomic barriers, drug costs, digital health tools, regimen simplification, pharmacist intervention, dementia, schizophrenia, institutionalized patients, cardiovascular events, financial assistance programs, cultural tailoring, mental health support, predictors of adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025). https://app.cochat.ai/papers/10.3390/jcm15052069
- The paper
- Mehany, O., Artner, A., Sebők, S., Hankó, B., & Zelkó, R. (2026). Multilevel Interventions to Improve Medication Adherence in Older Adults: A Systematic Review and Meta-Analysis of Cognitive, Digital, Behavioral, and Socioeconomic Strategies (2015–2025). Journal of Clinical Medicine. https://doi.org/10.3390/jcm15052069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.